Artal International S.C.A.

Artal International S.C.A. has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Cava Group, Inc., Lexicon Pharmaceuticals, Inc. and Scholar Rock Holding Corp. The record holds 21 filings, for trades running from 23 October 2012 to 18 November 2024.

Market trades split into 7 purchases (€272.4M) and 5 sales (€2.2B). Netting one side against the other leaves €1.9B of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant and 7 option exercises. 2024 to date brings no purchases and 5 sales.

Half of the purchases are above €28.8M and half below. Of 5 purchases, 4 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. For 7 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 29% of cases, with a median move of -12.7%. This is a record of the past, not a forecast.

The newest entry dates from 20 November 2024: an open-market sale of €1.0B, in Cava Group, Inc. The most recent open-market purchase was published on 5 June 2023, 1,253 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.